BECN2 Protein (Beclin-2)
Introduction
Becn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@klionsky2016]
<table> [@galluzzi2017]
<tr><th colspan="2" style="background:#e8f4ea;">BECN2 Protein</th></tr> [@bento2016]
<tr><td><b>Protein Name</b></td><td>Beclin-2</td></tr> [@karan2021]
<tr><td><b>Gene</b></td><td>[BECN2](/genes/becn2)</td></tr> [@nah2020]
<tr><td><b>UniProt ID</b></td><td>Q9U6C4</td></tr> [@wang2012]
<tr><td><b>Molecular Weight</b></td><td>46.2 kDa</td></tr> [@he2012]
<tr><td><b>Subcellular Localization</b></td><td>Golgi apparatus, Endosomes, Cytoplasm</td></tr>
<tr><td><b>Protein Family</b></td><td>Beclin family, PI3K complex</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>5q13.2</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Obesity, Cancer</td></tr>
</table>
</div>
Overview
BECN2 (Beclin-2) is a key regulator of autophagy that interacts with class I PI3K signaling pathways. It plays critical roles in both macroautophagy and selective autophagy, particularly targeting misfolded proteins and protein aggregates. BECN2 serves as a molecular bridge between nutrient sensing, growth factor signaling, and the autophagy machinery.
Protein Structure
...
BECN2 Protein (Beclin-2)
Introduction
Becn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@klionsky2016]
<table> [@galluzzi2017]
<tr><th colspan="2" style="background:#e8f4ea;">BECN2 Protein</th></tr> [@bento2016]
<tr><td><b>Protein Name</b></td><td>Beclin-2</td></tr> [@karan2021]
<tr><td><b>Gene</b></td><td>[BECN2](/genes/becn2)</td></tr> [@nah2020]
<tr><td><b>UniProt ID</b></td><td>Q9U6C4</td></tr> [@wang2012]
<tr><td><b>Molecular Weight</b></td><td>46.2 kDa</td></tr> [@he2012]
<tr><td><b>Subcellular Localization</b></td><td>Golgi apparatus, Endosomes, Cytoplasm</td></tr>
<tr><td><b>Protein Family</b></td><td>Beclin family, PI3K complex</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>5q13.2</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Obesity, Cancer</td></tr>
</table>
</div>
Overview
BECN2 (Beclin-2) is a key regulator of autophagy that interacts with class I PI3K signaling pathways. It plays critical roles in both macroautophagy and selective autophagy, particularly targeting misfolded proteins and protein aggregates. BECN2 serves as a molecular bridge between nutrient sensing, growth factor signaling, and the autophagy machinery.
Protein Structure
| Domain | Position | Function |
|--------|----------|----------|
| BH3 domain | 1-30 | Pro-apoptotic, binds Bcl-2 |
| CCD (Coiled-Coil Domain) | 112-243 | Dimerization, protein interactions |
| ECD (Evolutionarily Conserved Domain) | 244-450 | PI3K complex binding, membrane association |
| LIR (LC3-Interacting Region) | 269-280 | Autophagosome recruitment |
Expression Pattern
BECN2 exhibits tissue-specific expression:
- Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum
- [Neurons](/entities/neurons): Particularly abundant in pyramidal neurons and Purkinje cells
- Glia: Moderate expression in [astrocytes](/entities/astrocytes) and [microglia](/entities/microglia)
- Peripheral: Heart, liver, skeletal muscle with lower levels
- Development: Increased expression during synaptic plasticity periods
Normal Function
Autophagy Initiation
BECN2 forms part of the PI3K complex (VPS34/VPS15/BECN2) that generates PI3P on isolation membranes, a critical step in autophagosome nucleation.
Selective Autophagy Receptor
- Aggregate clearance: Recruits ubiquitinated protein aggregates to autophagosomes
- Organelle quality control: Mitophagy, reticulophagy
- Pathogen clearance: Xenophagy of intracellular pathogens
Signaling Integration
- mTORC1 coordination: Integrates growth factor and nutrient signals
- AMPK response: Energy stress activates BECN2-mediated autophagy
- Receptor tyrosine kinase signaling: Modulates EGFR and insulin receptor trafficking
Molecular Mechanisms
BECN2 assembles the class III PI3K complex:
| Component | Function |
|-----------|----------|
| VPS34 (PIK3C3) | Lipid kinase, generates PI3P |
| VPS15 (PIK3R4) | Regulatory subunit, kinase activity |
| BECN2 | Scaffold, substrate recruitment |
| ATG14L | Targeting to autophagosomes |
Autophagy Regulation
Initiation: BECN2-PI3P complex nucleates phagophore
Expansion: LC3-II recruited via LIR domain
Closure: Autophagosome membrane fusion
Fusion: Lysosomal fusion via SNARE proteinsProtein Interactions
| Partner | Interaction Type | Functional Outcome |
|---------|-----------------|-------------------|
|
BCL2/BCL-XL | BH3 domain binding | Inhibits autophagy |
|
VPS34 | CCD domain | PI3K complex |
|
LC3/GABARAP | LIR motif | Autophagosome targeting |
|
p62/SQSTM1 | Co-operation | Selective autophagy |
|
OPTN | Co-operation | Ubiquitin selective autophagy |
Role in Neurodegeneration
Alzheimer's Disease
- Amyloid clearance: BECN2-mediated autophagy clears [Aβ](/proteins/amyloid-beta) aggregates
- [Tau](/proteins/tau) pathology: Impaired autophagy contributes to [tau](/proteins/tau) accumulation
- Synaptic dysfunction: Autophagic-lysosomal pathway disruption in AD
- Neuronal vulnerability: BECN2 reduction in AD brain
Parkinson's Disease
- [α-Synuclein](/proteins/alpha-synuclein) clearance: BECN2-dependent mitophagy clears damaged mitochondria
- Mitochondrial quality control: PINK1/Parkin-BECN2 axis
- Lewy body formation: Impaired autophagic clearance
- Dopaminergic neuron survival: BECN2 protection in PD models
Huntington's Disease
- Mutant [huntingtin](/proteins/huntingtin-protein) clearance: [Autophagy](/entities/autophagy) induction via BECN2
- Aggregate removal: Reduction of mHTT aggregates
- Neuronal protection: BECN2 overexpression improves phenotype
ALS
- Protein aggregate clearance: [TDP-43](/proteins/tdp-43), SOD1 aggregate removal
- Axonal transport: Autophagosome-lysosome trafficking
- Motor neuron survival: BECN2 protective in mouse models
Therapeutic Implications
Autophagy Modulators
| Compound | Mechanism | Stage |
|----------|-----------|-------|
|
Rapamycin | [mTOR](/entities/mtor) inhibition | Preclinical |
|
Metformin | AMPK activation | Clinical trials |
|
Carbamazepine | Beclin-1 cleavage | Preclinical |
|
Vitamin D | BECN2 upregulation | Observational |
Gene Therapy Approaches
- AAV-BECN2: Viral delivery of BECN2
- BECN2 activators: Small molecule allosteric modulators
- miRNA targeting: Anti-miR therapy to upregulate BECN2
Combination Strategies
- Autophagy + proteasome: Dual-target approaches
- BECN2 + [TFEB](/entities/tfeb): Coordinated upregulation
- Anti-aggregation + clearance: Comprehensive therapy
Biomarkers
- BECN2 expression: Peripheral blood mononuclear cells
- Autophagy flux: LC3-II/LC3-I ratio
- p62 levels: Autophagy substrate clearance
Animal Models
Knockout Studies
- Becn2⁻/⁻ mice: Embryonic lethal (different from Becn1)
- Conditional knockout: Neurodegeneration phenotype
- Tissue-specific deletion: Neuronal loss, aggregate formation
Transgenic Models
- BECN2 overexpression: Neuroprotection in AD/PD models
- Humanized BECN2: Studying human-specific functions
- Mutant BECN2: Disease-associated variants
Key Findings
BECN2 haploinsufficiency enhances neurodegeneration
Autophagy induction protects against protein aggregates
BECN2-PI3K complex is druggable targetResearch Directions
Emerging Questions
- How does BECN2 specificity arise for different cargo?
- What determines neuronal vulnerability to BECN2 loss?
- Can BECN2 activation be achieved safely in humans?
Novel Approaches
- Single-cell proteomics: BECN2 heterogeneity in neurons
- CRISPR screens: Genetic modifiers of BECN2 function
- Structural biology: BECN2-PI3K complex cryo-EM
Background
The study of Becn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
- BECN2 Gene
- BECN1 Protein (Beclin-1)
- [GABARAPL2 Protein](/proteins/gabarapl2-protein)
- [MAP1LC3B2 Protein](/proteins/map1lc3b2-protein)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Huntington's Disease](/diseases/huntingtons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [UniProt: BECN2](https://www.uniprot.org/uniprot/Q9U6C4)
- [GeneCards: BECN2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=BECN2)
- [OMIM: BECN2](https://www.omim.org/entry/611539)
- [NCBI Gene: BECN2](https://www.ncbi.nlm.nih.gov/gene/151246)
References
[Mizushima N, Yoshimori T, Ohsumi Y, The role of Atg proteins in autophagosome formation (2011)](https://pubmed.ncbi.nlm.nih.gov/21801009/)
[Klionsky DJ, et al, Guidelines for the use and interpretation of assays for monitoring autophagy (2016)](https://pubmed.ncbi.nlm.nih.gov/26799652/)
[Galluzzi L, et al, Molecular definitions of autophagy and related processes (2017)](https://pubmed.ncbi.nlm.nih.gov/28923597/)
[Bento CF, et al, Mammalian autophagy: how does it work? Annu Rev Biochem (2016)](https://pubmed.ncbi.nlm.nih.gov/26865832/)
[Karan S, et al, Autophagy in neurodegenerative diseases: from pathogenesis to therapy (2021)](https://pubmed.ncbi.nlm.nih.gov/33737189/)
[Nah J, et al, Beclin-2 functions in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32632350/)
[Wang RC, et al, Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation (2012)](https://pubmed.ncbi.nlm.nih.gov/23112296/)
[He C, et al, Exercise-induced BCL2-mediated autophagy is required for muscle glucose homeostasis (2012)](https://pubmed.ncbi.nlm.nih.gov/22258505/)